Abacus Fcf Advisors LLC’s Bristol-Myers Squibb Co Position
Does Abacus Fcf Advisors LLC own Bristol-Myers Squibb Co (BMY)? Yes — 224.0K shares worth $14M (+3.06% of its 13F portfolio) as of Q1 2026, down from 385.1K shares the prior filed quarter.
Position Value
$14M
Q1 2026
Shares
224.0K
% of Portfolio
+3.06%
Quarters Held
20
currently held
Position History BMY
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 224.0K | $14M | +3.06% |
| Q4 2025 | 385.1K | $21M | +2.71% |
| Q3 2025 | 376.1K | $17M | +2.25% |
| Q2 2025 | 365.4K | $17M | +2.37% |
| Q1 2025 | 291.5K | $18M | +2.79% |
| Q4 2024 | 203.4K | $12M | +1.51% |
| Q3 2024 | 122.3K | $6M | +1.47% |
| Q2 2024 | 112.8K | $5M | +1.16% |
| Q1 2024 | 110.4K | $6M | +1.50% |
| Q4 2023 | 102.3K | $5M | +1.52% |
| Q3 2023 | 34.5K | $2M | +1.06% |
| Q2 2023 | 35.0K | $2M | +1.13% |
| Q1 2023 | 29.9K | $2M | +1.11% |
| Q4 2022 | 21.9K | $2M | +1.03% |
| Q3 2022 | 22.4K | $2M | +1.10% |
| Q2 2022 | 26.5K | $2M | +1.25% |
| Q1 2022 | 57.1K | $4M | +1.39% |
| Q4 2021 | 24.3K | $2M | +0.74% |
| Q3 2021 | 24.3K | $1M | +0.71% |
| Q2 2021 | 24.3K | $2M | +0.83% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Abacus Fcf Advisors LLC’s full portfolio or all institutional holders of BMY.